In 2001, a report on intralesional injection of phosphatidylcholine for the reduction of protuberant lower eyelid fat suggested that fat could be dissolved by this substance. Subsequently, physicians used phosphatidylcholine as a “fat burner” to reduce saddlebag trochanteric bulges (breeches) and pendulous abdomens.1 To prove the ability of phosphatidylcholine to reduce fat, a pilot study for the treatment of lipomas was designed (Table). It was conducted according to good clinical practice guidelines with ethics committee approval. Fifteen volunteers (5 women and 10 men) aged 21 to 64 years (median age, 43.5 years) with 19 lipomas in various body sites were recruited for the study. All sought treatment for functional or aesthetic reasons. At baseline, before the first treatment, and at the end of follow-up (week 12), photographic documentation was performed and ultrasound imaging was used to evaluate 3 dimensions of each lipoma: thickness, length, and diameter at a 90° angle to the length, and their volume was calculated as ellipsoids (v = a:2×b:2×c:2×π×4:3).
Kopera D, Binder B, Toplak H. Intralesional Lipolysis With Phosphatidylcholine for the Treatment of Lipomas: Pilot Study. Arch Dermatol. 2006;142(3):393–403. doi:10.1001/archderm.142.3.395
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.